Test nKBank nK- nKPharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach nK(9th nKEdition, nK2017)
PHARMACOLOGY nK9TH nKEDITION nKMCCUISTION nKTEST nKBANK
This nKis nKa nKset nKof nKquestions nKto nKanswer nKthe nKquestions nKof nKthe nKtextbook nK"Pharmacology: nKA
nKPatient-Centered nKNursing nKProcess nKApproach nK9th nKEdition" nKit nKhelps nKyou nKto nKbetter nKunderstand
nKthe nKbook nKcorrectly.
Get nKthe nKright nKdosage nKof nKpharmacology nKcontent nKto nKsucceed nKon nKthe nKNCLEX nKand nKas nKa
nKprofessional nKnurse nKwith nK"Pharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach, nK9th
nKEdition". nKUsing nKa nKstreamlined nKprototype nKapproach nKand nKan nKemphasis nKon nKnursing nKcare, nKthis
nKtext nKmakes nKit nKeasy nKfor nKtoday’s nKnursing nKstudents nKto nKbetter nKunderstand nKthe nKcomplicated
nKsubject nKof nKpharmacology. nKThe nKbook’s nKdetailed nKchapter nKon nKdosage nKcalculation, nKthe nKnursing
nKprocess nKframework nKfor nKdrug nKtherapy, nKstrong nKQSEN nKfocus, nKand nKsummaries nKof nKprototype
nKdrugs nKhelp nKdeliver nKthe nKperfect.
,Test nKBank nK- nKPharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach nK(9th
nKEdition, nK2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Table of Contents
nK nK
Table nKof Chapter nK28: nKPeptides, nKAntimalarial, nKand
nKContents
Chapter nK01: nKDrug nKDevelopment nKand Anthelmintic
nKEthical nKConsiderations Chapter nK29: nKHIV- nKand nKAIDS-Related
Chapter nK02: nKPharmacokinetics, nKDrugs
nKPharmacodynamics, nKand Chapter nK30: nKTransplant
nKPharmacogenetics nKDrugs nKChapter nK31:
Chapter nK03: nKCultural nKConsiderations nKVaccines nKChapter nK32:
nKChapter nK04: nKComplementary nKand nKAnticancer nKDrugs
nKAlternative nKTherapies Chapter nK33: nKTargeted nKTherapies nKto nKTreat
Chapter nK05: nKPediatric nKCancer
nKConsiderations nKChapter nK06: Chapter nK34: nKBiologic nKResponse
nKGeriatric nKConsiderations nKChapter nKModifiers
nK07: nKDrugs nKin nKSubstance nKUse Chapter nK35: nKUpper nKRespiratory
nKDisorder nKDisorders
Chapter nK08: nKThe nKNursing nKProcess Chapter nK36: nKLower nKRespiratory
nKand nKPatient-Centered nKCare nKDisorders
Chapter nK09: nKSafety nKand nKQuality Chapter nK37: nKCardiac nKGlycosides,
nKChapter nK10: nKDrug nKAdministration nKAntianginals, nKand nKAntidysrhythmics
nKChapter nK11: nKDrug nKCalculations nKChapter nK38: nKDiuretics
nKChapter nK12: nKFluid nKVolume nKand Chapter nK39: nKAntihypertensive
nKElectrolytes Chapter nK40: nKAnticoagulants,
Chapter nK13: nKVitamin nKand nKMineral nKAntiplatelets, nKand nKThrombolytics
nKReplacement nKChapter nK41: nKAntihyperlipidemics nKand
Chapter nK14: nKNutritional nKSupport nKPeripheral nKVasodilators
nKChapter nK15: nKAdrenergic nKAgonists Chapter nK42: nKGastrointestinal nKTract
nKand nKAntagonists nKDisorders
Chapter nK16: nKCholinergic nKAgonists Chapter nK43: nKAntiulcer nKDrugs
nKand nKAntagonists nKChapter nK44: nKEye nKand nKEar
Chapter nK17: nKStimulants nKDisorders nKChapter nK45:
Chapter nK18: nKDepressants nKDermatologic nKDisorders nKChapter
nKChapter nK19: nKAntiseizure nKDrugs nK46: nKPituitary, nKThyroid,
Chapter nK20: nKDrugs nKfor nKParkinsonism nKParathyroid, nKand nKAdrenal
nKand nKAlzheimer's nKDisease nKDisorders nKChapter nK47:
Chapter nK21: nKDrugs nKfor nKAntidiabetics
nKNeuromuscular nKDisorders nKand Chapter nK48: nKUrinary nKDisorders
nKMuscle nKSpasms nKChapter nK22: nKChapter nK49: nKPregnancy nKand
nKAntipsychotics nKand nKAnxiolytics nKPreterm nKLabor
Chapter nK23: nKAntidepressants nKand Chapter nK50: nKLabor, nKDelivery, nKand
nKMood nKStabilizers nKPostpartum
Chapter nK24: nKAntiinflammatories Chapter nK51: nKNeonatal nKand
Chapter nK25: nKAnalgesics nKNewborn nKChapter nK52: nKWomen's
Chapter nK26: nKAntibacterials nKReproductive nKHealth
Chapter nK27: nKAntituberculars, Chapter nK53: nKMen's nKReproductive nKHealth
nKAntifungals, nKand nKAntivirals nKChapter nK54: nKSexually nKTransmitted
nKInfections
Chapter nK55: nKAdult nKand nKPediatric
,Test nKBank nK- nKPharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach nK(9th
nKEdition, nK2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Emergency nKDrugs
, Test nKBank nK- nKPharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach nK(9th
nKEdition, nK2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
nK nK nK nK nK nK
MULTIPLE nKCHOICE
1. The nKnurse nKis nKpreparing nKto nKadminister nKa nKschedule nKII nKinjectable nKdrug nKand nKis
nKdrawing nKup nKhalf nKof nKthe nKcontents nKof nKa nKSingle-use nKvial. nKWhich nKnursing nKaction nKis
nKcorrect?
a. Ask nKanother nKnurse nKto nKobserve nKand nKcosign nKwasting nKthe nKremaining nKdrug nKfrom nKthe nKvial.
b. Keep nKthe nKremaining nKamount nKin nKthe nKpatient’s nKdrawer nKto nKgive nKat nKthe nKnext nKdose.
c. Record nKthe nKamount nKunused nKin nKthe nKpatient’s nKmedication nKrecord.
d. Dispose nKof nKthe nKvial nKwith nKthe nKremaining nKdrug nKinto nKa nKlocked
nKcollection nKbox. nKANS: nKA
Schedule nKII nKdrugs nKare nKcontrolled nKsubstances, nKand nKall nKmust nKbe nKaccounted nKfor. nKWhen
nKwasting nKa nKportion nKof nKa nKdrug, nKanother nKnurse nKshould nKobserve nKand nKcosign nKthat nKa nKdrug
nKwas nKwasted.
DIF: nKCOGNITIVE nKLEVEL: nKApplying
nK(Application) nKTOP: nKNURSING nKPROCESS:
nKNursing nKIntervention
MSC: nKNCLEX: nKPhysiological nKIntegrity: nKPharmacological nKand nKParenteral nKTherapies
2. A nKpatient nKis nKprescribed nKa nKmedication nKand nKasks nKthe nKnurse nKif nKthe nKdrug nKis nKavailable
nKin nKa nKgeneric nKform. nKThe nKnurse nKunderstands nKthat nKa nKgeneric nKmedication nKwill nKhave nKa
nKname nKthat
a. is nKa nKregistered nKtrademark.
b. is nKalways nKcapitalized.
c. describes nKthe nKdrugs nKchemical nKstructure.
d. is nKnon-
proprietary. nKANS:
nKD
The nKgeneric nKname nKis nKthe nKofficial, nKnon-proprietary nKname nKfor nKa nKdrug. nKThe nKbrand nKname
nKis nKthe nKtrademark nKname nKand nKis nKalways nKcapitalized. nKThe nKchemical nKname nKdescribes nKthe
nKchemical nKstructure nKof nKthe nKdrug.
DIF: nKCOGNITIVE nKLEVEL: nKUnderstanding
nK(Comprehension) nKTOP: nKNURSING nKPROCESS: nKN/A
MSC: nKNCLEX: nKPhysiological nKIntegrity: nKPharmacological nKand nKParenteral nKTherapies
3. A nKpatient nKreceives nKa nKprescription nKon nKwhich nKthe nKprovider nKhas nKnoted nKthat nKa nKgeneric
nKmedication nKmay nKbe nKgiven.The nKpatient nKasks nKthe nKnurse nKwhat nKthis nKmeans. nKWhat nKwill
nKthe nKnurse nKtell nKthe nKpatient nKabout nKgeneric nKdrugs?
a. They nKcontain nKthe nKsame nKinert nKingredients nKas nKbrand-name nKdrugs.
b. They nKhave nKchemical nKstructures nKthat nKare nKidentical nKto nKproprietary nKdrugs.
c. They nKtend nKto nKbe nKless nKexpensive nKthan nKbrand-name nKdrugs.
d. They nKundergo nKextensive nKtesting nKbefore nKthey nKare
nKmarketed. nKANS: nKC
Generic nKdrugs nKare nKapproved nKby nKthe nKFDA nKif nKthey nKare nKproved nKto nKbe nKbioequivalent nKto
nKthe nKbrand- nKname nKdrug. nKThey nKtend nKto nKbe nKless nKexpensive nKbecause nKmanufacturers nKof
nKthese nKdrugs nKdo nKnot nKhave nKto nKdo nKthe nKextensive nKtesting nKrequired nKof nKbrand-name nKdrugs
nKbefore nKmarketing. nKThey nKare nKnot nKidentical nKto nKbrand-name nKdrugs nKand nKoften nKhave
nKdifferent nKinert nKingredients.
DIF: nKCOGNITIVE nKLEVEL: nKApplying nK(Application)
TOP: nKNURSING nKPROCESS: nKNursing nKIntervention: nKPatient nKTeaching
nKMSC: nKNCLEX: nKManagement nKof nKClient nKCare
4. The nKnurse nKreviews nKinformation nKabout nKa nKdrug nKand nKnotes nKthe nKinitials nKUSP nKafter nKthe
PHARMACOLOGY nK9TH nKEDITION nKMCCUISTION nKTEST nKBANK
This nKis nKa nKset nKof nKquestions nKto nKanswer nKthe nKquestions nKof nKthe nKtextbook nK"Pharmacology: nKA
nKPatient-Centered nKNursing nKProcess nKApproach nK9th nKEdition" nKit nKhelps nKyou nKto nKbetter nKunderstand
nKthe nKbook nKcorrectly.
Get nKthe nKright nKdosage nKof nKpharmacology nKcontent nKto nKsucceed nKon nKthe nKNCLEX nKand nKas nKa
nKprofessional nKnurse nKwith nK"Pharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach, nK9th
nKEdition". nKUsing nKa nKstreamlined nKprototype nKapproach nKand nKan nKemphasis nKon nKnursing nKcare, nKthis
nKtext nKmakes nKit nKeasy nKfor nKtoday’s nKnursing nKstudents nKto nKbetter nKunderstand nKthe nKcomplicated
nKsubject nKof nKpharmacology. nKThe nKbook’s nKdetailed nKchapter nKon nKdosage nKcalculation, nKthe nKnursing
nKprocess nKframework nKfor nKdrug nKtherapy, nKstrong nKQSEN nKfocus, nKand nKsummaries nKof nKprototype
nKdrugs nKhelp nKdeliver nKthe nKperfect.
,Test nKBank nK- nKPharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach nK(9th
nKEdition, nK2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Table of Contents
nK nK
Table nKof Chapter nK28: nKPeptides, nKAntimalarial, nKand
nKContents
Chapter nK01: nKDrug nKDevelopment nKand Anthelmintic
nKEthical nKConsiderations Chapter nK29: nKHIV- nKand nKAIDS-Related
Chapter nK02: nKPharmacokinetics, nKDrugs
nKPharmacodynamics, nKand Chapter nK30: nKTransplant
nKPharmacogenetics nKDrugs nKChapter nK31:
Chapter nK03: nKCultural nKConsiderations nKVaccines nKChapter nK32:
nKChapter nK04: nKComplementary nKand nKAnticancer nKDrugs
nKAlternative nKTherapies Chapter nK33: nKTargeted nKTherapies nKto nKTreat
Chapter nK05: nKPediatric nKCancer
nKConsiderations nKChapter nK06: Chapter nK34: nKBiologic nKResponse
nKGeriatric nKConsiderations nKChapter nKModifiers
nK07: nKDrugs nKin nKSubstance nKUse Chapter nK35: nKUpper nKRespiratory
nKDisorder nKDisorders
Chapter nK08: nKThe nKNursing nKProcess Chapter nK36: nKLower nKRespiratory
nKand nKPatient-Centered nKCare nKDisorders
Chapter nK09: nKSafety nKand nKQuality Chapter nK37: nKCardiac nKGlycosides,
nKChapter nK10: nKDrug nKAdministration nKAntianginals, nKand nKAntidysrhythmics
nKChapter nK11: nKDrug nKCalculations nKChapter nK38: nKDiuretics
nKChapter nK12: nKFluid nKVolume nKand Chapter nK39: nKAntihypertensive
nKElectrolytes Chapter nK40: nKAnticoagulants,
Chapter nK13: nKVitamin nKand nKMineral nKAntiplatelets, nKand nKThrombolytics
nKReplacement nKChapter nK41: nKAntihyperlipidemics nKand
Chapter nK14: nKNutritional nKSupport nKPeripheral nKVasodilators
nKChapter nK15: nKAdrenergic nKAgonists Chapter nK42: nKGastrointestinal nKTract
nKand nKAntagonists nKDisorders
Chapter nK16: nKCholinergic nKAgonists Chapter nK43: nKAntiulcer nKDrugs
nKand nKAntagonists nKChapter nK44: nKEye nKand nKEar
Chapter nK17: nKStimulants nKDisorders nKChapter nK45:
Chapter nK18: nKDepressants nKDermatologic nKDisorders nKChapter
nKChapter nK19: nKAntiseizure nKDrugs nK46: nKPituitary, nKThyroid,
Chapter nK20: nKDrugs nKfor nKParkinsonism nKParathyroid, nKand nKAdrenal
nKand nKAlzheimer's nKDisease nKDisorders nKChapter nK47:
Chapter nK21: nKDrugs nKfor nKAntidiabetics
nKNeuromuscular nKDisorders nKand Chapter nK48: nKUrinary nKDisorders
nKMuscle nKSpasms nKChapter nK22: nKChapter nK49: nKPregnancy nKand
nKAntipsychotics nKand nKAnxiolytics nKPreterm nKLabor
Chapter nK23: nKAntidepressants nKand Chapter nK50: nKLabor, nKDelivery, nKand
nKMood nKStabilizers nKPostpartum
Chapter nK24: nKAntiinflammatories Chapter nK51: nKNeonatal nKand
Chapter nK25: nKAnalgesics nKNewborn nKChapter nK52: nKWomen's
Chapter nK26: nKAntibacterials nKReproductive nKHealth
Chapter nK27: nKAntituberculars, Chapter nK53: nKMen's nKReproductive nKHealth
nKAntifungals, nKand nKAntivirals nKChapter nK54: nKSexually nKTransmitted
nKInfections
Chapter nK55: nKAdult nKand nKPediatric
,Test nKBank nK- nKPharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach nK(9th
nKEdition, nK2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Emergency nKDrugs
, Test nKBank nK- nKPharmacology: nKA nKPatient-Centered nKNursing nKProcess nKApproach nK(9th
nKEdition, nK2017)
PHARMACOLOGY 9TH EDITION MCCUISTION TEST BANK
Chapter 01: Drug Development and Ethical Considerations
nK nK nK nK nK nK
MULTIPLE nKCHOICE
1. The nKnurse nKis nKpreparing nKto nKadminister nKa nKschedule nKII nKinjectable nKdrug nKand nKis
nKdrawing nKup nKhalf nKof nKthe nKcontents nKof nKa nKSingle-use nKvial. nKWhich nKnursing nKaction nKis
nKcorrect?
a. Ask nKanother nKnurse nKto nKobserve nKand nKcosign nKwasting nKthe nKremaining nKdrug nKfrom nKthe nKvial.
b. Keep nKthe nKremaining nKamount nKin nKthe nKpatient’s nKdrawer nKto nKgive nKat nKthe nKnext nKdose.
c. Record nKthe nKamount nKunused nKin nKthe nKpatient’s nKmedication nKrecord.
d. Dispose nKof nKthe nKvial nKwith nKthe nKremaining nKdrug nKinto nKa nKlocked
nKcollection nKbox. nKANS: nKA
Schedule nKII nKdrugs nKare nKcontrolled nKsubstances, nKand nKall nKmust nKbe nKaccounted nKfor. nKWhen
nKwasting nKa nKportion nKof nKa nKdrug, nKanother nKnurse nKshould nKobserve nKand nKcosign nKthat nKa nKdrug
nKwas nKwasted.
DIF: nKCOGNITIVE nKLEVEL: nKApplying
nK(Application) nKTOP: nKNURSING nKPROCESS:
nKNursing nKIntervention
MSC: nKNCLEX: nKPhysiological nKIntegrity: nKPharmacological nKand nKParenteral nKTherapies
2. A nKpatient nKis nKprescribed nKa nKmedication nKand nKasks nKthe nKnurse nKif nKthe nKdrug nKis nKavailable
nKin nKa nKgeneric nKform. nKThe nKnurse nKunderstands nKthat nKa nKgeneric nKmedication nKwill nKhave nKa
nKname nKthat
a. is nKa nKregistered nKtrademark.
b. is nKalways nKcapitalized.
c. describes nKthe nKdrugs nKchemical nKstructure.
d. is nKnon-
proprietary. nKANS:
nKD
The nKgeneric nKname nKis nKthe nKofficial, nKnon-proprietary nKname nKfor nKa nKdrug. nKThe nKbrand nKname
nKis nKthe nKtrademark nKname nKand nKis nKalways nKcapitalized. nKThe nKchemical nKname nKdescribes nKthe
nKchemical nKstructure nKof nKthe nKdrug.
DIF: nKCOGNITIVE nKLEVEL: nKUnderstanding
nK(Comprehension) nKTOP: nKNURSING nKPROCESS: nKN/A
MSC: nKNCLEX: nKPhysiological nKIntegrity: nKPharmacological nKand nKParenteral nKTherapies
3. A nKpatient nKreceives nKa nKprescription nKon nKwhich nKthe nKprovider nKhas nKnoted nKthat nKa nKgeneric
nKmedication nKmay nKbe nKgiven.The nKpatient nKasks nKthe nKnurse nKwhat nKthis nKmeans. nKWhat nKwill
nKthe nKnurse nKtell nKthe nKpatient nKabout nKgeneric nKdrugs?
a. They nKcontain nKthe nKsame nKinert nKingredients nKas nKbrand-name nKdrugs.
b. They nKhave nKchemical nKstructures nKthat nKare nKidentical nKto nKproprietary nKdrugs.
c. They nKtend nKto nKbe nKless nKexpensive nKthan nKbrand-name nKdrugs.
d. They nKundergo nKextensive nKtesting nKbefore nKthey nKare
nKmarketed. nKANS: nKC
Generic nKdrugs nKare nKapproved nKby nKthe nKFDA nKif nKthey nKare nKproved nKto nKbe nKbioequivalent nKto
nKthe nKbrand- nKname nKdrug. nKThey nKtend nKto nKbe nKless nKexpensive nKbecause nKmanufacturers nKof
nKthese nKdrugs nKdo nKnot nKhave nKto nKdo nKthe nKextensive nKtesting nKrequired nKof nKbrand-name nKdrugs
nKbefore nKmarketing. nKThey nKare nKnot nKidentical nKto nKbrand-name nKdrugs nKand nKoften nKhave
nKdifferent nKinert nKingredients.
DIF: nKCOGNITIVE nKLEVEL: nKApplying nK(Application)
TOP: nKNURSING nKPROCESS: nKNursing nKIntervention: nKPatient nKTeaching
nKMSC: nKNCLEX: nKManagement nKof nKClient nKCare
4. The nKnurse nKreviews nKinformation nKabout nKa nKdrug nKand nKnotes nKthe nKinitials nKUSP nKafter nKthe
